NCT05566288View on ClinicalTrials.gov

Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions
Smoking Cessation
Interventions
DRUG

Cytisinicline

compressed film-coated tablet containing 3 mg cytisinicline

DRUG

Placebo

Placebo tablets to match compressed film-coated tablet containing 3 mg cytisinicline

DRUG

Moxifloxacin

400 mg tablets

Trial Locations (1)

4250-449

BlueClinical Phase I, Porto

Sponsors
All Listed Sponsors
lead

Achieve Life Sciences

INDUSTRY